Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 25, 2010Medicinal Research Reviews

Prophylactic and therapeutic implications of toll‐like receptor ligands

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMona HedayatBeth Israel Deaconess Medical CenterKTKiyoshi TakedaHyogo University of Health Sciences
Nima Rezaei
Nima RezaeiEducation and Research Network

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hedayat et al. (2010) studied this question.

synapsesocial.com/papers/6a6fbb2f35aa2c282ce110d0https://doi.org/10.1002/med.20214
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives2007 · 475 citations
  2. 2CpG Oligodeoxyribonucleotides Rescue Mature Spleen B Cells from Spontaneous Apoptosis and Promote Cell Cycle Entry1998 · 244 citations
  3. 3Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 21999 · 1,710 citations
  4. 4The roles of TLRs, RLRs and NLRs in pathogen recognition2009 · 1,662 citations